Hannan Cathal John, Lewis Daniel, O'Leary Claire, Donofrio Carmine A, Evans Dafydd Gareth, Roncaroli Federico, Brough David, King Andrew Thomas, Coope David, Pathmanaban Omar Nathan
Manchester Centre for Clinical Neurosciences, Salford Royal Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
Division of Evolution & Genomic Sciences, School of Biological Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK.
Neurooncol Adv. 2020 Feb 27;2(1):vdaa023. doi: 10.1093/noajnl/vdaa023. eCollection 2020 Jan-Dec.
Vestibular schwannomas are tumors arising from the vestibulocochlear nerve at the cerebellopontine angle. Their proximity to eloquent brainstem structures means that the pathology itself and the treatment thereof can be associated with significant morbidity. The vast majority of these tumors are sporadic, with the remainder arising as a result of the genetic syndrome Neurofibromatosis Type 2 or, more rarely, related schwannomatosis. The natural history of these tumors is extremely variable, with some tumors not displaying any evidence of growth, others demonstrating early, persistent growth and a small number growing following an extended period of indolence. Emerging evidence now suggests that far from representing Schwann cell proliferation only, the tumor microenvironment is complex, with inflammation proposed to play a key role in their growth. In this review, we provide an overview of this new evidence, including the role played by immune cell infiltration, the underlying molecular pathways involved, and biomarkers for detecting this inflammation in vivo. Given the limitations of current treatments, there is a pressing need for novel therapies to aid in the management of this condition, and we conclude by proposing areas for future research that could lead to the development of therapies targeted toward inflammation in vestibular schwannoma.
前庭神经鞘瘤是起源于小脑脑桥角前庭蜗神经的肿瘤。它们靠近脑干部位的重要结构,这意味着肿瘤本身及其治疗可能会导致严重的发病率。这些肿瘤绝大多数是散发性的,其余的则是由2型神经纤维瘤病这一遗传综合征引起,或更罕见地,由相关的神经鞘瘤病引起。这些肿瘤的自然病程差异极大,有些肿瘤没有任何生长迹象,有些则早期持续生长,还有少数在长期静止后生长。新出现的证据表明,肿瘤微环境远非仅代表施万细胞增殖,而是复杂的,炎症被认为在其生长中起关键作用。在本综述中,我们概述了这一新证据,包括免疫细胞浸润所起的作用、涉及的潜在分子途径以及用于在体内检测这种炎症的生物标志物。鉴于当前治疗方法的局限性,迫切需要新的疗法来辅助管理这种疾病,我们通过提出未来研究领域来结束本文,这些领域可能会导致开发针对前庭神经鞘瘤炎症的疗法。